| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 13 | +38.46% | +0.85% | +0.15% | +0.70% | +1.64% | — |
| 14d | 13 | +84.62% | -3.97% | +0.94% | -4.92% | -6.88% | — |
| 30d | 13 | +61.54% | +0.73% | +3.27% | -2.54% | -4.70% | — |
| 60d | 13 | +7.69% | +14.10% | +5.13% | +8.96% | +14.28% | — |
| 90d | 13 | +7.69% | +15.54% | +8.23% | +7.30% | +16.00% | — |
| 180d | 13 | +7.69% | +18.59% | +11.36% | +7.24% | +7.72% | — |
| 1y | 13(6 pending) | +14.29% | +5.27% | +23.88% | -18.61% | -15.72% | — |
| 2y | 13(13 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ONC BEONE MEDICINES LTD. | SALE President, Global Head of R&D | 1,068 | $276.74 | $295.6K | 0 | Jun 23, 2026 | Jun 25, 2026 ↗ | View → |
| ONC BEONE MEDICINES LTD. | SALE President, Global Head of R&D | 1,169 | $265.39 | $310.2K | 0 | Jun 16, 2026 | Jun 18, 2026 ↗ | View → |
| ONC BEONE MEDICINES LTD. | PURCHASEGRANT Stock grant | 229,775 | — | — | 229,775 | Jun 11, 2026 | Jun 15, 2026 ↗ | View → |
| ONC BEONE MEDICINES LTD. | SALE President, Global Head of R&D | 756 | $261.00 | $197.3K | 0 | Jun 11, 2026 | Jun 15, 2026 ↗ | View → |
| ONC BEONE MEDICINES LTD. | PURCHASEGRANT Stock grant | 118,625 | — | — | 1,710,085 | Jun 11, 2026 | Jun 15, 2026 ↗ | View → |
| ONC BEONE MEDICINES LTD. | SALE President, Global Head of R&D | 40 | $270.73 | $10.8K | 0 | Jun 8, 2026 | Jun 10, 2026 ↗ | View → |
| ONC BEONE MEDICINES LTD. | SALE President, Global Head of R&D | 1,327 | $269.34 | $357.4K | 40 | Jun 8, 2026 | Jun 10, 2026 ↗ | View → |
| ONC BEONE MEDICINES LTD. | PURCHASEGRANT Stock grant | 55,029 | — | — | 1,619,059 | Mar 6, 2026 | Mar 10, 2026 ↗ | View → |
| ONC BEONE MEDICINES LTD. | PURCHASEGRANT Stock grant | 112,606 | — | — | 1,564,030 | Mar 6, 2026 | Mar 10, 2026 ↗ | View → |
| ONC BEONE MEDICINES LTD. | PURCHASEGRANT Stock grant | 427,895 | — | — | 1,451,424 | Dec 31, 2025 | Jan 5, 2026 ↗ | View → |
| ONC BEONE MEDICINES LTD. | SALE10b5-1 10b5-1 plan | 5,000 | $350.06 | $1.75M | 0 | Sep 9, 2025 | Sep 11, 2025 ↗ | View → |
| ONC BEONE MEDICINES LTD. | SALE10b5-1 10b5-1 plan | 259 | $305.00 | $79.0K | 0 | Jul 30, 2025 | Jul 31, 2025 ↗ | View → |
| ONC BEONE MEDICINES LTD. | SALE10b5-1 10b5-1 plan | 292 | $302.92 | $88.5K | 1,059 | Jul 29, 2025 | Jul 31, 2025 ↗ | View → |
| ONC BEONE MEDICINES LTD. | SALE10b5-1 10b5-1 plan | 800 | $304.16 | $243.3K | 259 | Jul 29, 2025 | Jul 31, 2025 ↗ | View → |
| ONC BEONE MEDICINES LTD. | SALE10b5-1 10b5-1 plan | 2,949 | $302.00 | $890.6K | 1,351 | Jul 29, 2025 | Jul 31, 2025 ↗ | View → |
| ONC BEONE MEDICINES LTD. | SALE10b5-1 10b5-1 plan | 700 | $300.00 | $210.0K | 0 | Jul 18, 2025 | Jul 22, 2025 ↗ | View → |
| ONC BEONE MEDICINES LTD. | SALE Global Head of R&D | 1,028 | $260.00 | $267.3K | 0 | Jun 23, 2025 | Jun 25, 2025 ↗ | View → |
| ONC BEONE MEDICINES LTD. | SALE Global Head of R&D | 470 | $251.37 | $118.1K | 0 | Jun 17, 2025 | Jun 18, 2025 ↗ | View → |
| ONC BEONE MEDICINES LTD. | SALE Global Head of R&D | 1,177 | $266.40 | $313.6K | 470 | Jun 16, 2025 | Jun 18, 2025 ↗ | View → |
| ONC BEONE MEDICINES LTD. | PURCHASEGRANT Stock grant | 86,359 | — | — | 1,058,304 | Jun 10, 2025 | Jun 12, 2025 ↗ | View → |
| ONC BEONE MEDICINES LTD. | PURCHASEGRANT Stock grant | 162,565 | — | — | 162,565 | Jun 10, 2025 | Jun 12, 2025 ↗ | View → |
| ONC BEONE MEDICINES LTD. | SALE Global Head of R&D | 300 | $253.19 | $76.0K | 300 | Jun 6, 2025 | Jun 10, 2025 ↗ | View → |
| ONC BEONE MEDICINES LTD. | SALE Global Head of R&D | 600 | $250.71 | $150.4K | 802 | Jun 6, 2025 | Jun 10, 2025 ↗ | View → |
| ONC BEONE MEDICINES LTD. | SALE Global Head of R&D | 300 | $255.30 | $76.6K | 0 | Jun 6, 2025 | Jun 10, 2025 ↗ | View → |
| ONC BEONE MEDICINES LTD. | SALE Global Head of R&D | 202 | $251.89 | $50.9K | 600 | Jun 6, 2025 | Jun 10, 2025 ↗ | View → |